Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Alcon Inc. Ordinary Shares
(NY:
ALC
)
76.61
+1.56 (+2.08%)
Official Closing Price
Updated: 7:00 PM EST, Nov 21, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Alcon Inc. Ordinary Shares
< Previous
1
2
3
4
5
6
7
8
9
Next >
Why Alcon Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
↗
May 14, 2024
Via
Benzinga
2 Intriguing Medical Stocks To Buy For Steady Growth As Earnings Approach
↗
May 14, 2024
Among the medical sector, Alcon and Prestige Consumer Healthcare are two intriguing stocks to buy for growth as their quarterly results approach on Tuesday, May 14.
Via
Talk Markets
Alcon Reports Strong First-Quarter 2024 Results Driven by Robust Sales in Contact Lenses and Ocular Health
May 13, 2024
From
Alcon Inc. Investors
Via
Business Wire
Alcon Announces Results of 2024 Annual General Meeting
May 08, 2024
From
Alcon Inc. Investors
Via
Business Wire
Alcon Inc. (NYSE: ALC) Records 52-Week High Tuesday Morning
March 12, 2024
Via
Investor Brand Network
What 6 Analyst Ratings Have To Say About Alcon
↗
December 04, 2023
Via
Benzinga
Star Surgical Shines as U.S. Outlook Improves for 2024
April 16, 2024
STAAR Surgical is increasing its outlook and guidance as demand for its signature IOL procedure increases with an aging population
Via
MarketBeat
Alcon Publishes Agenda for 2024 Annual General Meeting
April 07, 2024
From
Alcon Inc. Investors
Via
Business Wire
Vivity, the World’s Leading EDOF IOL, Reaches One Million Milestone
March 06, 2024
From
Alcon Inc. Corporate
Via
Business Wire
Alcon's Broad Portfolio Delivers Robust Sales and Earnings Growth in FY 2023
February 27, 2024
From
Alcon Inc. Investors
Via
Business Wire
The Latest Analyst Ratings for Alcon
↗
November 16, 2023
Via
Benzinga
Why Medical Device Company Alcon Shares Are Sliding Today
↗
November 15, 2023
Alcon Inc (NYSE: ALC) shares are trading lower by around 5%
Via
Benzinga
Earnings Preview: What To Expect To When Eye Health Company Bausch + Lomb Reports Q4 Performance Later This Month
↗
February 09, 2024
"Bausch + Lomb's Q4 & FY 2023 results on Feb 21, 2024. Expecting $1.107 billion in sales, $0.17 EPS. RBC Capital predicts $1.159 billion revenue. Insights on Miebo launch and enhanced EBITDA margins...
Via
Benzinga
Buy This Ophthalmology Stock But Sell This One, Says Bernstein Analyst: 'Innovation Is Key'
↗
January 23, 2024
Innovation and digitalization have been in focus among ophthalmology majors.
Via
Benzinga
Good News For Dry Eye Disease Patients: Eye Care Focused Alcon's Treatment Shows Encouraging Benefit In Late-Stage Trials
↗
January 10, 2024
Alcon (NYSE: ALC) released topline results from the two Phase 3 trials (COMET-2 and COMET-3) evaluating the efficacy and safety of AR-15512, a candidate treatment for the signs and symptoms of
Via
Benzinga
Alcon Announces Positive Topline Results From Phase 3 COMET Trials of AR-15512, a Novel Topical Drug Candidate for Dry Eye
January 09, 2024
From
Alcon Inc. Investors
Via
Business Wire
Where Alcon Stands With Analysts
↗
September 08, 2023
Via
Benzinga
Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements
January 05, 2024
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
Alcon to Present at 2024 Annual J.P. Morgan Healthcare Conference
December 27, 2023
From
Alcon Inc. Investors
Via
Business Wire
Intel To Rally Over 23%? Here Are 10 Top Analyst Forecasts For Thursday
↗
November 16, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
US Stocks On Track To Build On Gains As Traders Await A Batch Of Data; Can Market Resist Profit Taking?
↗
November 15, 2023
U.S. stocks could build on the momentum they picked up on Tuesday following the release of benign inflation data. Traders get to digest another batch of economic data on producer price inflation,...
Via
Benzinga
Topics
Economy
Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
November 15, 2023
Shares of Shapeways Holdings, Inc. (NASDAQ: SHPW) tumbled during Wednesday’s session following downbeat results.
Via
Benzinga
Varex Imaging Reports Weak Sales, Joins Alcon, XPeng And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
↗
November 15, 2023
U.S. stock futures traded higher this morning on Wednesday, with the Dow Jones futures gaining more than 90 points this morning.
Via
Benzinga
Topics
Stocks
Alcon Reports Third Quarter 2023 Results
November 14, 2023
From
Alcon Inc. Investors
Via
Business Wire
Alcon Gears Up For Q3 Print; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts
↗
November 14, 2023
Alcon Inc. (NYSE: ALC) is projected to release financial results for its third quarter, after the closing bell on Nov. 14, 2023.
Via
Benzinga
Alcon Showcases Cloud-based Planning and World-class Digital Technologies During AAO 2023
October 30, 2023
From
Alcon Inc. Investors
Via
Business Wire
Alcon Launches TOTAL30 Multifocal Contact Lenses for Patients with Presbyopia
October 10, 2023
From
Alcon Inc. Investors
Via
Business Wire
Cataract Surgery with Alcon’s AcrySof IQ Vivity IOLs Demonstrates Sustained High Patient Satisfaction and Reduced Spectacle Dependence
September 09, 2023
From
Alcon Inc. Corporate
Via
Business Wire
Global Dry Eye Syndrome Treatment Market Expected to Reach $11.26 Billion By 2030
September 08, 2023
EQNX::TICKER_START (NASDAQ:OKYO),(NYSE:ALC),(NYSE:BLCO),(NYSE:JNJ),(OTCQX:RHHBY) EQNX::TICKER_END
Via
FinancialNewsMedia
Alcon Announces its Largest-Ever Scientific Program at the 41st Congress of the ESCRS, Showcasing New Data and Innovation to Support Ophthalmic Surgical Teams
September 06, 2023
From
Alcon Inc. Corporate
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today